SLC12A1 and Wilson disease: Total protein abundance of NKCC2 in both cortex (Figure 3A) and medulla (Figure 3B), and NKCC2 mRNA levels in the medulla (Figure 3D) but not cortex (Figure 3C), were elevated after WD in the vehicle group, which were completely abolished by apelin-13 treatment.